Depression in women with polycystic ovary syndrome: Clinical and biochemical correlates

Journal of Affective Disorders

Volumn 74, Issue 3, 2003, Pages 299-304

  Rasgon, Natalie L ^a   Rao, Rekha C ^a   Hwang, Sun ^a   Altshuler, Lori L ^a   Elman, Shana ^a   Zuckerbrow Miller, Joni ^a   Korenman, Stanley G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Depression; Hirsutism; Hyperandrogenism; Insulin resistance; Obesity; Polycystic ovary syndrome

Indexed keywords

CONTRACEPTIVE AGENT;

AGE DISTRIBUTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN RESISTANCE; MEDICAL ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; SCREENING TEST;

EID: 0038401375     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00117-9     Document Type: Article

References (32)

1. Baischer W., Koinig G., Hartmann B., Huber J., Langer G. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology. 20:(5):1995;553-559.
2. Bruce-Jones W., Zolese G., White P. Polycystic ovary syndrome and psychiatric morbidity. J. Psychosom. Obstet. Gynecol. 14:1993;111-116.
3. Brunswick D.J., Frazer A., Koslow S.H., Casper R., Stokes P.E., Robins E., Davis J.M. Insulin-induced hypoglycemic response and release of growth hormone in depressed patients and healthy controls. Psychol. Med. 18:(1):1988;79-91.
4. Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57:1983;356-369.
5. Chiba M., Suzuki S., Hinokio Y., Hirai M., Satoh Y., Tashiro A., et al. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism: Clin. Exp. 49:2000;1145-1149.
6. Coyne J.C., Fechner-Bates S., Schwenk T.L. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen. Hosp. Psychiatry. 16:1994;267-276.
7. Dunaif A., Segal K.R., Futterweit W., Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 38:1989;1165-1174.
8. Fava G.A., Grandi S., Savron G., Bartolucci G., Santarsiero G., Trombini G., et al. Psychosomatic assessment of hirsute women. Psychother. Psychosom. 51:(2):1989;96-100.
9. Figlewicz D.P. Endocrine regulation of neurotransmitter transporters. Epilepsy Res. 37:(3):1999;203-210.
10. Franks S. Polycystic ovary syndrome. New Engl. J. Med. 333:1995;853-861.
11. Futterweit W. CME review article 18: polycystic ovary syndrome: clinical perspectives and management. Obstet. Gynecol. Surv. 54:(6):1999;403-413.
12. Gonzalez F. Adrenal involvement in polycystic ovary syndrome. Semin. Reprod. Endocrinol. 15:(2):1997;137-157.
13. Horacek J., Kuzmiakova M., Hoschl C., Andel M., Bahbonh R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers. Psychoneuroendocrinology. 24:1999;785-797.
14. Istvan J., Zavela K., Weidner G. Body weight and psychological distress in NHANES I. Int. J. Obes. 16:1992;999-1003.
15. Judd L., Akiskal H.S., Paulus M.P. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J. Affect. Disord. 45:1997;5-17.
16. Koslow S.H., Stokes P.E., Mendels J., Ramsey A., Casper R. Insulin tolerance test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects. Psychol. Med. 12:1982;45-55.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
18. McCarty M.F. Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression-an adjuvant role for chromium picolinate? Med. Hypotheses. 43:(4):1994;247-252.
19. Menna-Perper M., Rochford J., Mueller P.S., Swartzburg M., Jekelis A.W., Manowitz P. Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients. Psychoneuroendocrinology. 9:(2):1984;161-171.
20. Nathan R.S., Sachar E.J., Asnis G.M., Halbreich U., Halpern F.S. Relative insulin insensitivity and cortisol secretion in depressed patients. Psychiatry Res. 4:(3):1981;291-300.
21. Okamura F., Tashiro A., Utsumi A., Imai T., Suchi T., Hongo M. Insulin resistance in patients with depression and its changes in the clinical course of depression: a report on three cases using the minimal model analysis. Internal Med. 38:(3):1999;257-260.
22. Okamura F., Tashiro A., Utsumi A., Imai T., Suchi T., Tamura D., Sato Y., Suzuki S., Hongo M. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism. 49:(10):2000;1255-1260.
23. Patten S.B., Lamarre C.J. Can drug-induced depressions be identified by their clinical features? Can. J. Psychiatry. Revue Canadienne de Psychiatrie. 37:1992;213-215.
24. Rao R.C., Rasgon N.L., Hwang S., Altshuler L.L., Zuckerbrow-Miller J., Korenman S. Prevalence of depression in women with polycystic ovary syndrome. Abstract, American Psychiatric Association, New Orleans, Louisiana, May:2001.
25. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol. Measur. 1:1977;385-401.
26. Rasgon N.L., Altshuler L.L., Gudeman D., Burt V.K., Tanavoli S., Hendrick V., et al. Medication status and PCO syndrome in women with bipolar disorder: a preliminary report. J. Clin. Psychiatry. 61:2000;173-178.
27. Schulberg H.C., Saul M., McClelland M., Ganguli M., Christy W., Frank R. Assessing depression in primary medical and psychiatric practices. Arch. Gen. Psychiatry. 42:1985;1164-1170.
28. Shulman L.H., DeRogatis L., Spielvogel R., Miller J.L., Rose L.I. Serum androgens and depression in women with facial hirsutism. J. Am. Acad. Dermatol. 27:1992;178-181.
29. Weber B., Lewicka S., Deuschle M., Colla M., Heuser I. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology. 25:2000;765-771.
30. Winokur A., Maislin G., Phillips J.L., Amsterdam J.D. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am. J. Psychiatry. 145:(3):1988;325-330.
31. Yen S.S.C. Chronic anovulation caused by peripheral endocrine disorders. Yen S.S.C., Jaffe R.B. Reproductive Endocrinology: Physiology, Pathophysiology and Clin. Management. 3rd Edition:1991;576-630 W.B. Saunders, Philadelphia.
32. Zich J.M., Attkisson C.C., Greenfield T.K. Screening for depression in primary care clinics: the CES-D and the BDI. Intl. J. Psychiatry Med. 20:(3):1990;259-277.